The market for Penicillins and Streptomycins in dosage form in the Czech Republic has shown a fluctuating trend over the years, with a significant decline from 2013 to 2015 and a brief recovery phase in 2018. As of 2023, the market size stands at USD 60.391 million, marking a decrease from previous years. The year-on-year change for 2023 shows a decrease of 3.18%, while the compound annual growth rate (CAGR) over the last five years indicates an average annual decrease of 4.46%.
Future trends to watch for in the Czech market include:
- Potential impact of emerging antibiotic resistance, which may affect the demand for existing drugs.
- The introduction of new antimicrobial agents, potentially influencing market dynamics.
- Economic and healthcare policy changes that could alter market accessibility and drug pricing strategies.
- Increasing importance of sustainability and environmental considerations in pharmaceutical production.
How does the Czech Republic rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 16 | 16 Chile | 68,962,000 | 2023 | +0.58% | +0.71% | View data |
| 17 | 17 Malaysia | 62,268,000 | 2023 | +7.35% | +7.89% | View data |
| 18 | 18 Czech Republic | 60,391,000 | 2023 | -3.18% | -4.46% | |
| 19 | 19 New Zealand | 59,707,000 | 2023 | -1.18% | -1.53% | View data |
| 20 | 20 Portugal | 50,167,000 | 2023 | +0.83% | -0.0056% | View data |
